Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate
<< Previous | New Search | Return to Search Results | Next >>

Krystyna Kiel, MD

Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Oncology, Radiation
  • Therapeutic Radiology
Board Certification:
  • Therapeutic Radiology
Faculty Rank: Associate Professor
Medical or Graduate Education: University of Massachusetts Medical School
Residency: Massachusetts General Hospital - Radiation Oncology
Clinical Expertise:
  • Breast cancer
  • Gynecologic cancer
Languages Spoken:
  • English
Google Map
  • University Radiation Medicine
  • Woman's Board Center for Radiation Therapy
  • 500 S. Paulina St.
  • Ground Floor
  • Chicago, IL  60612
  • Phone: (312) 942-6817
  • Fax: (312) 942-2857
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer.
    Refaat T, Choi M, Gaber G, Kiel K, Mehta M, Gradishar W, Small W Jr.
    Am J Clin Oncol. 2013
    2013 Feb 5. [Epub ahead of print]
  2. International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting.
    Salminen EK, Kiel K, Ibbott GS, Joiner MC, Rosenblatt E, Zubizarreta E, Wondergem J, Meghzifene A.
    Radiat Oncol. 2011
    2011 Feb 4
    6:11. doi: 10.1186/1748-717X-6-11.
  3. Change in creatinine clearance over time following upper abdominal irradiation: a dose-volume histogram multivariate analysis.
    Diavolitsis VM, Rademaker A, Boyle J, Kang Z, Kiel K, Mulcahy M, Small W Jr.
    Am J Clin Oncol. 2011
    2011 Feb
    34(1):53-7. doi: 10.1097/COC.0b013e3181d27080.
  4. Residual disease after neoadjuvant chemotherapy for breast cancer.
    Morris GJ, Robinson PA, Lo S, Samuel TA, Sheikh AA, Jordan WE 3rd, Thomas LC, Kiel K, Peters CA.
    Semin Oncol. 2010
    2010 Feb
    37(1):1-10. doi: 10.1053/j.seminoncol.2009.12.001. No abstract available.
  5. NCCN Clinical Practice Guidelines in Oncology: rectal cancer.
    Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, et al.
    J Natl Compr Canc Netw. 2009
    2009 Sep
    7(8):838-81. No abstract available.
  6. NCCN Clinical Practice Guidelines in Oncology: colon cancer.
    Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, et al.
    J Natl Compr Canc Netw. 2009
    2009 Sep
    7(8):778-831. No abstract available.
  7. Ensuring optimal interdisciplinary breast care in the United States.
    Anderson BO, Carlson RW, Kaufman CS, Kiel KD.
    Breast J. 2009
    2009 Nov-Dec
    15(6):569-70. doi: 10.1111/j.1524-4741.2009.00832.x. No abstract available.
  8. Breast cancer. Clinical practice guidelines in oncology.
    Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, et al.
    J Natl Compr Canc Netw. 2009
    2009 Feb
    7(2):122-92. Review. No abstract available.
  9. Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer.
    Hazard HW, Gorla SR, Scholtens D, Kiel K, Gradishar WJ, Khan SA.
    Cancer. 2008
    2008 Oct 15
    113(8):2011-9. doi: 10.1002/cncr.23870.
  10. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
    Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R.
    J Clin Oncol. 2008
    2008 Mar 1
    26(7):1086-92. doi: 10.1200/JCO.2007.12.9593.
  11. Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer.
    Wahl AO, Rademaker A, Kiel KD, Jones EL, Marks LB, Croog V, McCormick BM, Hirsch A, Karkar A, Motwani SB, Tereffe W, Yu TK, Sher D, Silverstein J, Kachnic LA, Kesslering C, Freedman GM, Small W Jr.
    Int J Radiat Oncol Biol Phys. 2008
    2008 Feb 1
    70(2):477-84. Epub 2007 Sep 14.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612